Additional recommendation on the use of obesity medications in diabetes patients is provided in the updated guidelines. The American Diabetes Association ® (ADA) has released its latest evidence-based ...

There are fundamental differences in the pathogenesis and course of type 2 diabetes between young people and adults that necessitate a different approach in youth with the disease, with an emphasis on ...

SEATTLE — The latest American Association of Clinical Endocrinology (AACE) type 2 diabetes management algorithm uses graphics to focus on individualized care while adding newly compiled information ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2025 ADA Standards of Care includes updated ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2026 update of AACE’s consensus statement algorithm ...

The American Diabetes Association’s 2026 Standards of Care now recommend continuous glucose monitoring (CGM) for everyone newly diagnosed with type 2 diabetes, expanding its use beyond ...

Pharmacy Times Continuing Education™ (PTCE) presented new research at the American Diabetes Association (ADA) 2026 Scientific Sessions, held June 5–8 in New Orleans, Louisiana. The ADA Scientific ...

Orforglipron is beneficial for blood glucose control in individuals with type 2 diabetes using metformin or taking insulin glargine.

For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study ...